Skip to content
Surf Wiki
Save to docs
general/chronic-blistering-cutaneous-conditions

From Surf Wiki (app.surf) — the open knowledge base

Transient acantholytic dermatosis


FieldValue
nameGrover's disease
synonymsbenign papular acantholytic dermatosis, transient acantholytic dermatosis, persistent acantholytic dermatosis
imageTransient acantholytic dermatosis - very high mag.jpg
captionMicrograph of transient acantholytic dermatosis, showing subcorneal separation and acantholysis. H&E stain.

| Grover's disease (GD) is a polymorphic, pruritic, papulovesicular dermatosis characterized histologically by acantholysis with or without dyskeratosis. Once confirmed, most cases of Grover's disease last six to twelve months, which is why it was originally called "transient". However it may last much longer. Nevertheless, it is not to be confused with relapsing linear acantholytic dermatosis.

Signs and symptoms

The itchy eruption lasts an average of 10–12 months. It is characterized by papules and papulovesicles with excoriations occurring on the chest, back, lower sternum, arms, and thighs. The papules are most commonly found on the mid chest.

Sometimes the features of Grover's are found in people who do not itch or have a conspicuous rash. Most of the people with Grover's who visit a dermatologist, however, itch a lot.

Cause

The cause of Grover's disease is unknown. Suspected triggers of disease activity include heat and sweating, sunlight, and adverse reaction to medications as well as ionizing radiation, end-stage renal disease/hemodialysis, and mechanical irritation or prolonged bed rest.

Some cases of Grover's disease have been associated with medications such as sulfadoxine-pyrimethamine, ribavirin, cetuximab, and interleukin-4 [1,8-15]. One series of 300 patients with Grover's disease reported an association with other coexisting dermatoses including atopic dermatitis, contact dermatitis, and xerosis cutis. More recent reports have indicated a connection with the Moderna vaccine for Covid-19 and as a presenting symptom of SARS-CoV-2 infection itself. Finally, smaller series have detailed an association with pyoderma gangrenosum, bacterial and viral infections, and occasionally, malignancies.

Diagnosis

Grover's may be suspected by its appearance, but since it has such a characteristic appearance under the microscope a shave skin or punch biopsy is often performed.

Treatment

Sweating causes lesions to form, but lesions aggravated by sweat usually return to "normal" fairly quicklyavoiding sweat is not considered a reason to avoid exercise. Minor outbreaks can be controlled with prescription strength topical cortisone creams. More severe eruptions usually clear up after treatment for one to three months with isotretinoin or tetracycline. If these fail or the outbreak is severe, PUVA phototherapy treatments, antifungal medication and cortisone injections are alternatives.

Some research has suggested a correlation of Grover's disease with mercury toxicity in which case Dimercaptosuccinic acid might help.

Epidemiology

The prevalence and incidence of Grover's disease have not been firmly established. In a study from Switzerland, Grover's disease was diagnosed in just 24 of more than 30,000 skin biopsies. Grover's disease is mainly seen in males over the age of forty.

Grover's disease affects chiefly white adults in the fifth decade or later, and appears to be around 1.6 to 2.1 times more common in men than in women. Grover's disease appears less commonly in darker-skinned individuals.

History

This condition was first reported in 1975 by the American dermatopathologist, Ralph Wier Grover (1920–2008) while working at Franklin Hospital in New York. He described and examined around 40 patients having the characteristic signs of the disease, which now bears his name.

References

References

  1. Rapini, Ronald P.. (2007). "Dermatology: 2-Volume Set". Mosby.
  2. Freedberg, et al. (2003). ''Fitzpatrick's Dermatology in General Medicine''. (6th ed.). McGraw-Hill. {{ISBN. 0-07-138076-0.
  3. Scheinfeld NS, Mones J. (2006). "Seasonal variation of transient acantholytic dyskeratosis (Grover's disease)". J Am Acad Dermatol.
  4. "Grover's Disease".
  5. (1984). "The association of transient acantholytic dermatosis with other skin diseases". Journal of the American Academy of Dermatology.
  6. (2021). "The histologic and molecular correlates of COVID-19 vaccine-induced changes in the skin". Clinics in Dermatology.
  7. (2024). "A Grover-Like Skin Rash: A Potential Indicator of Underlying Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection". Cureus.
  8. "Grover's Disease - American Osteopathic College of Dermatology (AOCD)".
  9. Dantzig PI. (Jul 2006). "Parkinson's disease, macular degeneration and cutaneous signs of mercury toxicity". J Occup Environ Med.
  10. Dantzig PI. (2005). "Age-Related Macular Degeneration and Cutaneous Signs of Mercury Toxicity". Cutaneous and Ocular Toxicology.
  11. "Could I Have Grover's Disease? Is It Just a Skin Rash?". WebMD.
  12. (February 2022)
  13. (2010). "In memoriam: Dr Ralph Wier Grover". Journal of the American Academy of Dermatology.
  14. Ferri, FF.. (2009). "Ferri's Color Atlas and Text of Clinical Medicine". Saunders.
Info: Wikipedia Source

This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.

Want to explore this topic further?

Ask Mako anything about Transient acantholytic dermatosis — get instant answers, deeper analysis, and related topics.

Research with Mako

Free with your Surf account

Content sourced from Wikipedia, available under CC BY-SA 4.0.

This content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.

Report